Tsuneharu Miki

Saiseikai Shigaken Hospital — Japan

Medicine · Health Sciences

51h-index11.0kcitations603works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Prostate Cancer Diagnosis and Treatment(73), Prostate Cancer Treatment and Research(71), Urinary Bladder and Prostate Research(70), Renal cell carcinoma treatment(62), Bladder and Urothelial Cancer Treatments(54)

Publications602 total

A blind spot in cognitive evaluation for risk of falls in older patients in rehabilitation wards: A nested case–control study
Geriatrics and gerontology international/Geriatrics & gerontology international·2024
Data from Differential and Common DNA Repair Pathways for Topoisomerase I- and II-Targeted Drugs in a Genetic DT40 Repair Cell Screen Panel
2023Open Access
Data from Differential and Common DNA Repair Pathways for Topoisomerase I- and II-Targeted Drugs in a Genetic DT40 Repair Cell Screen Panel
2023Open Access
Supplementary Figure S4: The combination induces apoptosis in a TRAIL-independent manner in UM-UC-11 cells. from A Histone Deacetylase Inhibitor, OBP-801, and Celecoxib Synergistically Inhibit the Cell Growth with Apoptosis via a DR5-Dependent Pathway in Bladder Cancer Cells
2023Open Access
Supplementary Figure S4: The combination induces apoptosis in a TRAIL-independent manner in UM-UC-11 cells. from A Histone Deacetylase Inhibitor, OBP-801, and Celecoxib Synergistically Inhibit the Cell Growth with Apoptosis via a DR5-Dependent Pathway in Bladder Cancer Cells
2023Open Access
Data from A Histone Deacetylase Inhibitor, OBP-801, and Celecoxib Synergistically Inhibit the Cell Growth with Apoptosis via a DR5-Dependent Pathway in Bladder Cancer Cells
2023Open Access
Supplementary Figure S1: Combined treatment with OBP-801 and celecoxib reduces FLIP and survivin expression at mRNA level. from A Histone Deacetylase Inhibitor, OBP-801, and Celecoxib Synergistically Inhibit the Cell Growth with Apoptosis via a DR5-Dependent Pathway in Bladder Cancer Cells
2023Open Access
Supplementary Figure S1: Combined treatment with OBP-801 and celecoxib reduces FLIP and survivin expression at mRNA level. from A Histone Deacetylase Inhibitor, OBP-801, and Celecoxib Synergistically Inhibit the Cell Growth with Apoptosis via a DR5-Dependent Pathway in Bladder Cancer Cells
2023Open Access
Data from A Histone Deacetylase Inhibitor, OBP-801, and Celecoxib Synergistically Inhibit the Cell Growth with Apoptosis via a DR5-Dependent Pathway in Bladder Cancer Cells
2023Open Access
Supplementary Figure S2: Expressions of DR5 mRNA and cell-surface DR5 are different between two bladder cancer cell lines. from A Histone Deacetylase Inhibitor, OBP-801, and Celecoxib Synergistically Inhibit the Cell Growth with Apoptosis via a DR5-Dependent Pathway in Bladder Cancer Cells
2023Open Access
Supplementary Table and Supplementary Figures 1 through 4 from Differential and Common DNA Repair Pathways for Topoisomerase I- and II-Targeted Drugs in a Genetic DT40 Repair Cell Screen Panel
2023Open Access
Supplementary Table and Supplementary Figures 1 through 4 from Differential and Common DNA Repair Pathways for Topoisomerase I- and II-Targeted Drugs in a Genetic DT40 Repair Cell Screen Panel
2023Open Access
Supplementary Figure S2: Expressions of DR5 mRNA and cell-surface DR5 are different between two bladder cancer cell lines. from A Histone Deacetylase Inhibitor, OBP-801, and Celecoxib Synergistically Inhibit the Cell Growth with Apoptosis via a DR5-Dependent Pathway in Bladder Cancer Cells
2023Open Access
Suuplementary Figure S3: Combined treatment with OBP-801 and celecoxib induces binding of caspase-8 to DR5, and Bim expression in bladder cancer cells. from A Histone Deacetylase Inhibitor, OBP-801, and Celecoxib Synergistically Inhibit the Cell Growth with Apoptosis via a DR5-Dependent Pathway in Bladder Cancer Cells
2023Open Access
Suuplementary Figure S3: Combined treatment with OBP-801 and celecoxib induces binding of caspase-8 to DR5, and Bim expression in bladder cancer cells. from A Histone Deacetylase Inhibitor, OBP-801, and Celecoxib Synergistically Inhibit the Cell Growth with Apoptosis via a DR5-Dependent Pathway in Bladder Cancer Cells
2023Open Access
Supplementary Figure 5 from DDX31 Regulates the p53-HDM2 Pathway and rRNA Gene Transcription through Its Interaction with NPM1 in Renal Cell Carcinomas
2023Open Access
Supplementary Methods, Figure 1, Table 1 from Myocardin Functions as an Effective Inducer of Growth Arrest and Differentiation in Human Uterine Leiomyosarcoma Cells
2023Open Access
Supplementary Figure 2 from DDX31 Regulates the p53-HDM2 Pathway and rRNA Gene Transcription through Its Interaction with NPM1 in Renal Cell Carcinomas
2023Open Access
Data from Molecular Features of Hormone-Refractory Prostate Cancer Cells by Genome-Wide Gene Expression Profiles
2023Open Access
Supplementary Figure 7 from Cell-Permeable Peptide DEPDC1-ZNF224 Interferes with Transcriptional Repression and Oncogenicity in Bladder Cancer Cells
2023Open Access
page 1 of 31Next →

Frequent Co-authors

Yoichi Mizutani(15), Akihiro Kawauchi(11), Kazuya Mikami(9), Taro Shuin(9), Osamu Ukimura(9), Tomoaki Fujioka(8), Toyomasa Katagiri(7), Äkïhïko Okuyama(7), Koji Okihara(7), Masahiro Nakao(6), Ryo Takata(6), Toshiyuki Sakai(6), Fumiya Hongo(5), Natsuki Takaha(5), Shingo Ashida(5), Tatsuhiko Tsunoda(5), Kazumi Kamoi(5), Benjamin Bonavida(5), Kotaro Ozasa(4), Hidewaki Nakagawa(4)